Posted in | News

Advanced Ultra-High Performance Liquid Chromatography Systems Enhance Lab Productivity

Image Credits: Thermo Fisher Scientific

The analytical complexity of new and emerging pharmaceuticals and biopharmaceuticals can now be met with advanced ultra-high performance liquid chromatography (UHPLC) systems designed to streamline workflows and help reduce cost per sample.

The next-generation Thermo Scientific Vanquish Duo UHPLC systems are designed to maximize throughput and return on investment (ROI), while providing scientists with a robust and comprehensive understanding of their samples. The systems make their debut at Pittcon 2018 (booth 2353) at the Orange County Convention Center in Orlando.

The increasing demand being placed on the pharmaceutical and biopharmaceutical industry to deliver safe and effective medicines that meet regulatory standards is presenting a unique set of analytical challenges. The Vanquish Duo UHPLC systems provide a high-throughput and robust solution required to enable full characterization of small and large molecules in a manner that creates confidence and quality, while helping to protect customers’ investment.

Fabrizio Moltoni, Vice President and General Manager, HPLC, Thermo Fisher Scientific

Each system in the Vanquish Duo UHPLC family enables scientists to meet different analytical and resource challenges:

  • The Vanquish Duo for Dual LC system runs two applications in parallel on a single instrument –whether used for identical analysis to double throughput or for different analysis for deeper sample knowledge. The system can increase capacity and performance without sacrificing bench space.
  • The Vanquish Duo for Tandem LC or LC-MS system is designed to provide maximum sample throughput and positive ROI by eliminating column reconditioning to maximize detector/mass spectrometer utilization. The system splits the analysis between two pumps, delivering a configuration that allows two identical columns to be run sequentially. One pump delivers the analytical gradient while the second pump delivers the recondition gradient intended to provide faster analysis without compromising data quality.
  • The Vanquish Duo for Inverse Gradient enhances detection for Thermo Fisher’s innovative charged aerosol detection (CAD) technology. The inverse gradient is formulated to provide a uniform CAD response under gradient elution conditions – allowing users to reliably quantify the compounds in a sample without bias – providing a robust and sensitive, cost-effective analytical solution.

The analytical power of the Vanquish Duo UHPLC systems is maximized through integration with Thermo Scientific Chromeleon Chromatography Data System (CDS) software, which streamlines workflows through intelligent software tools targeting easy method transfer and independent control of two flow paths in one effective analytical system.

For more information, please visit www.thermofisher.com/VanquishDuo.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thermo Fisher Scientific. (2018, February 28). Advanced Ultra-High Performance Liquid Chromatography Systems Enhance Lab Productivity. AZoM. Retrieved on April 26, 2024 from https://www.azom.com/news.aspx?newsID=48843.

  • MLA

    Thermo Fisher Scientific. "Advanced Ultra-High Performance Liquid Chromatography Systems Enhance Lab Productivity". AZoM. 26 April 2024. <https://www.azom.com/news.aspx?newsID=48843>.

  • Chicago

    Thermo Fisher Scientific. "Advanced Ultra-High Performance Liquid Chromatography Systems Enhance Lab Productivity". AZoM. https://www.azom.com/news.aspx?newsID=48843. (accessed April 26, 2024).

  • Harvard

    Thermo Fisher Scientific. 2018. Advanced Ultra-High Performance Liquid Chromatography Systems Enhance Lab Productivity. AZoM, viewed 26 April 2024, https://www.azom.com/news.aspx?newsID=48843.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.